Alerts will be sent to your verified email
Verify EmailBIOGEN
Biogen Pharmachem
|
Rama Vision
|
Amrapali Industries
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
0.21 % | 6.61 % | 2.68 % |
5yr average Equity Multiplier
|
1.01 | 1.69 | 5.43 |
5yr Average Asset Turnover Ratio
|
0.02 | 1.86 | 152.48 |
5yr Avg Net Profit Margin
|
-19.83 % | 1.98 % | 0.0 |
Price to Book
|
0.88 | 2.63 | 2.42 |
P/E
|
66.97 | 29.95 | 45.12 |
5yr Avg Cash Conversion Cycle
|
0.0 | 69.81 Days | 0.2 Days |
Inventory Days
|
0.0 | 77.95 Days | 0.28 Days |
Days Receivable
|
0.0 | 19.66 Days | 0.0 |
Days Payable
|
1109.22 Days | 6.81 Days | 0.3 Days |
5yr Average Interest Coverage Ratio
|
902.8 | 4.22 | 1.17 |
5yr Avg ROCE
|
0.21 % | 11.41 % | 21.59 % |
5yr Avg Operating Profit Margin
|
-19.88 % | 4.78 % | 0.02 % |
5 yr average Debt to Equity
|
0.0 | 0.43 | 2.08 |
5yr CAGR Net Profit
|
n/a | 143.01 % | 14.37 % |
5yr Average Return on Assets
|
0.21 % | 3.69 % | 0.61 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 54.22 % | 73.43 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 1.84 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Biogen Pharmachem
|
Rama Vision
|
Amrapali Industries
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|